<DOC>
<DOCNO>
EP-0005607
</DOCNO>
<TEXT>
<DATE>
19791128
</DATE>
<IPC-CLASSIFICATIONS>
C07D-405/04 C07D-335/00 C07D-413/14 A61P-25/18 C07D-409/00 C07D-417/04 <main>C07D-409/04</main> C07D-405/00 C07D-335/16 C07D-335/18 C07D-409/06 A01N-43/34 C07D-417/00 C07D-409/04 A61K-31/435 A61K-31/445 A61P-25/00 C07D-413/00 A01N-43/40 C07D-409/14 
</IPC-CLASSIFICATIONS>
<TITLE>
xanthone and thioxanthone derivatives, their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
kefalas asdk<sep>kefalas a/s  <sep>kefalas a/s7-9 ottiliavejdk-2500 copenhagen-valbydk<sep>kefalas a/s<sep>
</APPLICANT>
<INVENTOR>
bigler allan johan<sep>bogeso klaus peter<sep>buus jorn lasse martin<sep>hansen peter bregnedal<sep>lassen niels<sep>bigler, allan johan<sep>bogeso, klaus peter<sep>buus, jorn lasse martin<sep>hansen, peter bregnedal<sep>lassen, niels<sep>bigler, allan johan17 bergthorasgadedk-2300 copenhagen s.dk<sep>bogeso, klaus peter15 molleaaparkendk-2800 kgs.lyngbydk<sep>buus, jorn lasse martin163 skovbovejdk-4632, bjaeverskovdk<sep>hansen, peter bregnedal44 gogevangendk-2970 horsholmdk<sep>lassen, niels15 gentoftegadedk-2820 gentoftedk<sep>bigler, allan johan<sep>bogeso, klaus peter <sep>buus, jorn lasse martin<sep>hansen, peter bregnedal  <sep>lassen, niels<sep>bigler, allan johan17 bergthorasgadedk-2300 copenhagen s.dk<sep>bogeso, klaus peter15 molleaaparkendk-2800 kgs.lyngbydk<sep>buus, jorn lasse martin163 skovbovejdk-4632, bjaeverskovdk<sep>hansen, peter bregnedal44 gogevangendk-2970 horsholmdk<sep>lassen, niels15 gentoftegadedk-2820 gentoftedk<sep>
</INVENTOR>
<ABSTRACT>
xanthone- and thioxanthone derivatives of the formula:    wherein x is a halogen atom, an alkyl group, an alkyloxy  group, said alkyl and alkyloxy groups having from one to  four carbon atoms inclusive, a methylthio group, a methylsuphonyl  group, a dimethylsulphamoyl group, a trifluoromethyl  group, or an acetyl group;   y is hydrogen, fluorine or a methyl group;   z is oxygen or sulphur;   n is an integer from zero to three inclusive, and   r is a cycloalkyl group with from four to six carbon  atoms inclusive in the ring, substituted with from one to four  substituents selected from optionally esterified hydroxy- or  hydroxymethyl groups, methyl groups, amono groups,  acetamino groups, mesylamino groups or oxo groups, a five- or  six-membered saturated heterocyclic ring having one or  two hetero atoms selected from oxygen and nitrogen atoms  and being optionally substituted with an optionally esterified  hydroxy group, any esterified hydroxy group present being  an ester of an aliphatic carboxylic acid having from ten to  twentytwo carbon atoms inclusive, or an oxo group, as well  as their non-toxic pharmaceutically acceptable acid addition  salts.  methods for the preparation of compounds of formula i  and novel intermediates used in said methods.  the novel compounds of formula i having strong, and  sometimes very long-lasting neuroleptic effects, at the same  time showing relatively low extrapyrimidal side effects, a low  acute toxicity and moderately strong anticholinergic effects  and comparatively low undesired sedative effects.  
</ABSTRACT>
</TEXT>
</DOC>
